Alex Martins

Alex Martins

Auto-generated profile, based on publicly available information

Alex Martins

Universidade do Estado do Amazonas (UEA). Manaus (AM), Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2019 in Journal of Information Systems and Technology Management
Verified
Journal Article
Open access
PDF file
RVRejane da Silva Viana
Rejane da Silva Viana
AMAlex Martins
Alex Martins
VMVivian Silva Lima Marangoni
Vivian Silva Lima Marangoni
ABAlessandro Bezerra
Alessandro Bezerra
This article aims to present the Telehealth system implemented at indigenous villages in the state of Amazonas, Brazil. Faced with the peculiar configurations of the state of Amazonas, Telehealth and all its tools can alleviate the deficiency in the number of active health professionals working in this region, giving access to health, especially in indigenous villages. Although the Federal Constitution of 1988 brought the concept of universalization of healthcare, it is known that the legislation alone does not make this right into reality. In this context, the implementation of the Telehealth tool is presented as an innovative format, with possibilities to reach out to a larger number of locations with difficult access. The indigenous population in the state of Amazonas is large in comparison to the other states of the federation, and amongst the thirty-four (34) indigenous districts, seven (7) are entirely within the state's borders and are areas of great territorial extension. This research may contribute to the discussions about the need to seek innovative formats for healthcare of the indigenous population in remote regions. Key words: Amazonas, Amazon, Telehealth, indigenous populations, remote regions, healthcare.

24 July 2026 in Revista Brasileira de Cancerologia
Verified
Journal Article
Open access
PDF file
JPJonathan Queen Rosas Pereira
Jonathan Queen Rosas Pereira
AOAriano Wagner Alves de Oliveira
Ariano Wagner Alves de Oliveira
LALucas Lorran Costa de Andrade
Lucas Lorran Costa de Andrade
ETElizabeth Teixeira
Elizabeth Teixeira
AMAlex Martins
Alex Martins
TUThalyta Mariany Rêgo Ueno
Thalyta Mariany Rêgo Ueno
Introdução: O câncer do colo do útero, também conhecido como câncer cervical, é uma forma de câncer que se origina nas células do colo do útero, a parte inferior do útero que se conecta à vagina. Esse câncer é frequentemente causado pela infecção persistente com tipos de papilomavírus humano (HPV) oncogênicos, como o HPV-16 e o HPV-18, que são transmitidos principalmente por via sexual. Objetivo: Compreender barreiras e facilitadores das usuárias do Sistema Único de Saúde (SUS) à realização do exame Papanicolau e formas de prevenção do câncer do colo do útero. Método: Estudo descritivo com abordagem qualitativa, realizado com 20 usuárias do SUS de duas Unidades Básicas de Saúde de Manaus/AM — localizadas nas Zonas Leste e Oeste da cidade. A coleta se deu por entrevistas semiestruturadas, conduzidas com roteiro próprio. Os dados foram submetidos à análise de redes temáticas. Resultados: Emergiram oito temas de organização e um tema global. As barreiras englobam principalmente dias de coleta e rotina de trabalho. Como facilitadores, destacam-se a presença do profissional do sexo feminino e a implementação da educação em saúde individualizada. Conclusão: As usuárias apresentam alta vulnerabilidade, mas mantêm elevada adesão ao exame citopatológico. Embora quase todas realizem o exame anualmente, a continuidade do rastreamento depende de boa informação, qualidade do atendimento e vínculo com os profissionais.

7 August 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AMAlex Martins
Alex Martins
MOMaria Luiza Carvalho de Oliveira
Maria Luiza Carvalho de Oliveira
MNManoel Luiz Neto
Manoel Luiz Neto
MBMarianna Brock
Marianna Brock
TUThalyta Mariany Rêgo Ueno
Thalyta Mariany Rêgo Ueno
EFElione dos Santos Ferreira
Elione dos Santos Ferreira
Objetivo: relatar a experiência de vacinação contra H1N1 durante pandemia de COVID-19 no Amazonas. Métodos: Trata-se de uma pesquisa histórica com abordagem qualitativa, do tipo relato de experiência. Foi realizada por meio de três ações de vacinação nas dependências de uma Universidade Pública do Amazonas para docentes e técnicos administrativos da Instituição. Resultados: A ação realizada em 3 dias, resultou na administração de 425 doses de vacina Influenza Tetravalente para docentes e discentes dos cursos de Enfermagem, Odontologia e Medicina da UEA. Foram utilizados dois métodos de vacinação em diferentes locais e formatos (Drive-Thru e Salas de Imunização tradicionais) para ampliar os meios de imunização. Conclusão: Para além da descrição da ação de vacinação, para proteção e mitigação de outras síndromes respiratórias que possam vir a atrapalhar o diagnóstico de COVID-19, a ação descrita no estudo também pode contribuir e socializar o desenvolvimento de práticas de prevenção a saúde dos profissionais que estão atuando diretamente na pandemia.

22 June 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAlex Martins
Alex Martins
MSMario Felipe Bosco Santos
Mario Felipe Bosco Santos
JNJoabi Nascimento
Joabi Nascimento
FCFabíola Mendonça da Silva Chui
Fabíola Mendonça da Silva Chui
MRMaria Gabriela Almeida Rodrigues
Maria Gabriela Almeida Rodrigues
MLMarcus Vinícius Guimarães de Lacerda
Marcus Vinícius Guimarães de Lacerda
CoronaVac, an inactivated SARS-CoV-2 vaccine, was one of the first deployed during the COVID-19 pandemic. Given the limited vaccine availability and the urgent need to assess effectiveness in target populations, a risk-based allocation clinical trial was designed to generate evidence under the ethical and logistical constraints at the beginning of the COVID-19 vaccination. In Manaus, Brazil, participants working in public service (education and public safety) aged 18–49 years were assessed regarding the risk of severe COVID-19 disease. Participants with one or more comorbidities, who were considered at higher risk of severe COVID-19 outcomes if infected, were allocated to early vaccination, while participants without comorbidities were enrolled as an unvaccinated comparison group. Blood samples were collected before each vaccine dose (D0 and D28) and during in-person follow-up visits (D90 and D180). Additional information was obtained through phone calls. Clinical cases of COVID-19, hospitalizations, deaths, and antibody titrations were the evaluated endpoints, considered after the second week following the second dose of the vaccine. A total of 6,226 participants were included: 1,139 in the low-risk group, and 5,087 in the high-risk vaccinated group. COVID-19 incidence was statistically significantly lower ( p < 0.001) in the vaccinated group at D28 (5.2% vs. 40.9%) and D90 (10.3% vs 31.6%). Hospitalization and death rates were low, with no difference observed between the groups. There was a decline in highly reactive titers at D180 in the vaccinated group. This pioneer risk-based allocation clinical trial provided evidence that CoronaVac reduced the risk of severe COVID-19 outcomes among individuals with comorbidities, effectively aligning their risk with that of lower-risk, unvaccinated individuals. Beyond its clinical implications, the study underscores the importance of adaptive, real-world research designs in rapidly generating actionable evidence in response to emerging public health threats. ClinicalTrials.gov Registration: NCT04789356

18 December 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
TUThalyta Mariany Rêgo Ueno
Thalyta Mariany Rêgo Ueno
NNNaelly Gonçalves Nascimento
Naelly Gonçalves Nascimento
MSMarisa Melo de Souza
Marisa Melo de Souza
ISIANNY FERREIRA RAIOL SOUSA
IANNY FERREIRA RAIOL SOUSA
JGJuliana Conceição Dias Garcez
Juliana Conceição Dias Garcez
AMAlex Martins
Alex Martins
The study aims to identify research in the health area on the use of ayahuasca related to the religious context, from 2017 to 2021. Descriptive research, of the Integrative Literature Review (RIL) type. As inclusion criteria, we used articles available in Portuguese, English and Spanish, complete articles and that were between the years 2017 to 2021. The databases used were the Virtual Health Library (VHL) and PubMed. Data collection was performed using the adapted Ursi form and data analysis using Bardin. 9 articles were selected. Quantitative analysis identified 6 (66.6%) in pubmed and most of the year 2020. 4 (44.4%) were built mainly by pharmacists. From the qualitative analysis, four thematic categories were listed: Ayahuasca and treatment for chemical dependency; Ayahuasca in the treatment of psychological disorders; The legitimacy and concern with the commercialization of ayahuasca; Ayahuasca and Spirituality. The RIL allowed identifying national and international scientific evidence on the use of ayahuasca in the religious context, thus making it possible to achieve the objective of the research. Despite still being considered a little discussed and stigmatized subject, the articles allowed the identification of relevant findings.